1. Home
  2. RMCO vs MYO Comparison

RMCO vs MYO Comparison

Compare RMCO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royalty Management Holding Corporation

RMCO

Royalty Management Holding Corporation

N/A

Current Price

$2.83

Market Cap

37.9M

Sector

Miscellaneous

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.73

Market Cap

44.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMCO
MYO
Founded
2021
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Industrial Specialties
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
44.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
RMCO
MYO
Price
$2.83
$1.73
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
14.8K
646.3K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
0.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,949,916.00
$1,000,000,000.00
Revenue This Year
$209.10
$9.10
Revenue Next Year
$133.33
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
513.30
40814.79
52 Week Low
$1.71
$0.61
52 Week High
$5.00
$1.89

Technical Indicators

Market Signals
Indicator
RMCO
MYO
Relative Strength Index (RSI) 59.92 65.54
Support Level $2.72 $0.69
Resistance Level $3.04 N/A
Average True Range (ATR) 0.25 0.18
MACD 0.01 0.05
Stochastic Oscillator 61.62 83.82

Price Performance

Historical Comparison
RMCO
MYO

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: